Literature DB >> 32233867

Medullary thyroid cancer: epidemiological pattern and factors contributing to recurrence and metastasis.

O Hamdy1, S Awny1, I H Metwally1.   

Abstract

INTRODUCTION: Medullary thyroid carcinoma (MTC) is a neuroendocrine thyroid carcinoma with parafollicular C cell differentiation. It can occur in either sporadic or hereditary form. Surgery is still the only curative treatment. The efficacy of chemotherapy and radiotherapy is poor.
METHODS: This was a retrospective study of 31 patients treated surgically for MTC in our oncology centre at Mansoura University between January 2008 and February 2019.
RESULTS: The mean age at diagnosis was 39.9 years. The median pathological size was 4cm. Multifocal disease was found in 12 patients and extrathyroid extension in 3 cases. Twenty patients were pathologically node positive. The median number of positive lymph nodes was four. Seven cases were metastatic at diagnosis. Local recurrence occurred in six individuals while distant recurrence occurred only in one. The median time from surgery to local recurrence was 12 months. The estimated mean disease free survival was 56.5 months. Disease free survival was significantly related to age, metastasis and side of nodal spread.
CONCLUSIONS: In our study cohort, the disease occurred predominantly in women and younger patients. Age, distant metastasis and nodal spread were the most significant prognostic factors. This study has also demonstrated that prognosis is not only affected by nodal involvement but also by side of involvement. The role of hemithyroidectomy in node negative unifocal disease with a small tumour size warrants further investigation.

Entities:  

Keywords:  Medullary carcinoma; Neck dissection; Recurrence; Survival; Thyroid cancer

Mesh:

Year:  2020        PMID: 32233867      PMCID: PMC7450426          DOI: 10.1308/rcsann.2020.0056

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  18 in total

Review 1.  Surgical management of medullary thyroid carcinoma.

Authors:  Agathoklis Konstantinidis; Michael Stang; Sanziana A Roman; Julie Ann Sosa
Journal:  Updates Surg       Date:  2017-04-13

2.  Medullary thyroid carcinoma: a 25-year perspective.

Authors:  Xavier Matias-Guiu; Ronald De Lellis
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

3.  Treating medullary thyroid carcinoma in a tertiary center. Current trends and review of the literature.

Authors:  E Prokopakis; M Doulaptsi; A Kaprana; S Velegrakis; Y Vlastos; G Velegrakis
Journal:  Hippokratia       Date:  2014-04       Impact factor: 0.471

4.  Timing and extension of lymphadenectomy in medullary thyroid carcinoma: A case series from a single institution.

Authors:  Andrea Polistena; Alessandro Sanguinetti; Roberta Lucchini; Sergio Galasse; Massimo Monacelli; Stefano Avenia; Andrea Boccolini; Louis Banka Johnson; Nicola Avenia
Journal:  Int J Surg       Date:  2017-05       Impact factor: 6.071

Review 5.  Advances and controversies in the management of medullary thyroid carcinoma.

Authors:  Ana Luiza Maia; Simone Magagnin Wajner; Carla Vaz Ferreira Vargas
Journal:  Curr Opin Oncol       Date:  2017-01       Impact factor: 3.645

Review 6.  Management of medullary thyroid carcinoma and MEN2 syndromes in childhood.

Authors:  Steven G Waguespack; Thereasa A Rich; Nancy D Perrier; Camilo Jimenez; Gilbert J Cote
Journal:  Nat Rev Endocrinol       Date:  2011-08-23       Impact factor: 43.330

7.  Cabozantinib in progressive medullary thyroid cancer.

Authors:  Rossella Elisei; Martin J Schlumberger; Stefan P Müller; Patrick Schöffski; Marcia S Brose; Manisha H Shah; Lisa Licitra; Barbara Jarzab; Viktor Medvedev; Michael C Kreissl; Bruno Niederle; Ezra E W Cohen; Lori J Wirth; Haythem Ali; Colin Hessel; Yifah Yaron; Douglas Ball; Barry Nelkin; Steven I Sherman
Journal:  J Clin Oncol       Date:  2013-09-03       Impact factor: 44.544

Review 8.  Current update on medullary thyroid carcinoma.

Authors:  Dhakshinamoorthy Ganeshan; Erik Paulson; Cihan Duran; Maria E Cabanillas; Naifa L Busaidy; Chusilp Charnsangavej
Journal:  AJR Am J Roentgenol       Date:  2013-12       Impact factor: 3.959

Review 9.  Medullary thyroid carcinoma.

Authors:  Marcio L Griebeler; Hossein Gharib; Geoffrey B Thompson
Journal:  Endocr Pract       Date:  2013 Jul-Aug       Impact factor: 3.443

Review 10.  Recent Updates on the Management of Medullary Thyroid Carcinoma.

Authors:  Bo Hyun Kim; In Joo Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2016-08-26
View more
  1 in total

1.  Clinical Characteristics, Surgical Management, and Prognostic Factors of Medullary Thyroid Carcinoma: A Retrospective, Single-Center Study.

Authors:  Xin Wu; Binglu Li; Chaoji Zheng
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.